KWESST Micro Systems Inc. will showcase its cutting-edge tactical systems at an international event, reflecting increased interest from public safety ...
Shares of G1 Therapeutics plunged 46% after disappointing results from their Phase 3 trilaciclib combination trial for triple-negative breast cancer. ...